Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Safety Group ECRI Reminds Hospitals That FDA’s EUA Process A ‘Lower Standard’ For Device Approvals

Executive Summary

The nonprofit patient safety group ECRI that focuses on device safety and efficacy warns about medtech with EUAs in its “2021 Top 10 Health Technology Hazards.”

You may also be interested in...



Too-Rapid Adoption Of Telehealth Can Lead To Suboptimal Patient Care, ECRI Says

Telehealth programs may cause risks to patients if they don’t provide sufficient user training or prove unable to overcome technology inequalities, ECRI says.

Surgical Stapler Misuse Tops ECRI’s 2020 Top 10 Medtech Hazards List

Surgical stapler misuse, point-of-care ultrasound issues and unproven surgical robotic procedures all rank high for 2020 in ECRI Institute’s annual "Top 10 Health Technology Hazards" report.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest News
UsernamePublicRestriction

Register

MT143407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel